EGFR and breast carcinoma: In vitro, knocking down TGFA did not reduce breast cancer cell production of MCSF, but did reduce the expression of CCL2, leading the authors to conclude that breast cancer cell-derived TGFα induced autocrine EGFR signaling, leading to increased CCL2 and macrophage recruitment [65].